✨ 10 results found - Searched 21219 records in 5ms.
Tesis
Proporsi asam deoksiribonukleat cytomegalovirus dari jaringan kanker paru karsinoma bukan sel kecil di RSUP Persahabatan
2024 | BY Ibrahim Nur Insan Putra Dharmawan - Jamal Zaini - Irandi Putra Pratomo - Eylin- Proportion of cytomegalovirus deoxyribonucleic acid from nonsmall cell lung cancer at Persahabatan Hospital.
- Nomor Panggil T24257fk
Skripsi
Hasil Pemeriksaan Immuno-Chromatography Test (ICT) LD Bio Aspergillus dibandingkan dengan IgG spesifik Aspergillus pada Pasien Kanker Paru Karsinoma Bukan Sel Kecil (KPKBSK) di RSUP Persahabatan
2020 | BY Asiyah Taqiyya Fakhrur Razi - Jamal Zaini- Comparison of Immuno-Chromatography Test (ICT) LD Bio Aspergillus with Aspergillus-specific lgG in Non-Small Cell Lung Cancer (NSCLC) Patients at Persahabatan General Hospital.
- Nomor Panggil S20164fk
Disertasi
Peran MiR-10b, MiR-21, SuPAR dan PAI-1 Sebagai Prediktor Respons Terapi dan Progresivitas pada Kanker Paru Jenis Karsinoma Bukan Sel Kecil (KPKBSK).
2017 | BY Lyana Setiawan - Noorwati Sutandyo - Siti Boedina Kresno - Rahajuningsih Setiabudy- The Role of MiR-10b, MiR-21, Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), and Plasminogen Activator Inhibitor (PAI)-1 as Predictors of Treatment Response and Progressivity in Non-Small Cell Lung Cancer (NSCLC).
- Nomor Panggil D17020fk
Tesis
Efikasi dan Toksisiti Erlotinib/Gefitinib sebagai Terapi Lini Kedua Pada Pasien Kanker Paru Jenis Karsinoma Bukan Sel Kecil
2015 | BY Sita Laksmi Andarini - Jamaluddin M. - Achmad Hudoyo- Efficacy and Toxicity Erlotinib/Gefitinib as Second Line Therapy in Non-Small Cell Lung Cancer Patients.
- Nomor Panggil T 15 543 FK
Tesis
Cell-free DNA sebagai Faktor Prognosis Kanker Paru Karsinoma Bukan Sel Kecil
2020 | BY Hana Khairina Putri Faisal - Noboru Hattori - Eiso Hiyama- Cell-free DNA as Prognosis Factor in Non-Small Cell Lung Cancer.
- Nomor Panggil T20483fk
Tesis
Analisis Potensi Interaksi Obat Pada Tatalaksana Kanker Paru Karsinoma Bukan Sel Kecil (KPKBSK) Stage Lanjut di RS Kanker Dharmais Tahun 2023
2024 | BY Anggi Gayatri - Purwantyastuti Ascobat - Noorwati Soetandyo - Yolanda Safitri- Analysis of Potential Drug Interactions in the Management of Non-Small Cell Carcinoma Lung Cancer (NSCLC) Advanced Stage at Dharmais Cancer Hospital in 2023.
- Nomor Panggil T24404fk
Tesis
Proporsi gambaran penyakit paru interstisial pada pasien kanker paru karsinoma bukan sel kecil dengan terapi epidermal growth factor receptor tyrosine kinase inhibitor di RSUP Persahabatan
2023 | BY Marscha Iradyta Ais - Sita Laksmi Andarini - Dianiati Kusumo Sutoyo - Maryastuti- The proportion of interstial lung disease features in patients with non small cell lung cancer treated with epidermal growth factor receptors tyrosine kinase inhibitor at Persahabatan Hospital.
- Nomor Panggil T23187fk
Tesis
Prevalens Penyakit Paru Obstruksi Kronik (PPOK) dan Emfisema Berdasarkan Pemeriksaan Spirometri dan Computed Tomography Scanning (CT-scan) Toraks Pada Pasien Kanker Paru di Rumah Sakit Umum Pusat Persahabatan
2019 | BY Prima Belia Fathana - Faisal Yunus - Sita Laksmi Andarini - Aziza G. Icksan- Prevalence of Chronic Obstructive Pulmonary Disease and Emphysema Based on Spirometry and Thorax CT-scan among Lung Cancer Patients Treated at Persahabatan Hospital Jakarta, Indonesia.
- Nomor Panggil T19279fk
Tesis
Masa tahan Hidup Pasien Kanker Paru Jenis Karsinoma Jenis Sel Kecil yang Mendapat Monoterapi Dosetaksel sebagai Kemoterapi Lini Kedua dan Faktor Faktor yang Mempengaruhi
2014 | BY Fadlun Bukayer - Anwar Jusuf - Elisna Syahruddin- SURVIVAL RATE OF DOCETAXEL AS SECONDLINE CHEMOTHERAPY FOR NSCLC PATIENTS IN PERSAHABATAN HOSPITAL JAKARTA.
- Nomor Panggil T14334fk
Tesis
Karakteristik, Angka Tahan Hidup dan faktor Prognostik Pasien Kanker Paru Jenis Karsinoma
2014 | BY Ratna Andriani - Elisna Syahruddin - Ahmad Hudoyo- Characteristics, Survival rate and Prognostic Factor of Small Cell Lung Cancer Patients
- Nomor Panggil T14325fk